Safety, Tolerability and Pharmacokinetics of Half-Life Extended SARS-CoV-2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab/Cilgavimab) in Healthy Adults.

Pablo Forte-SotoMuna AlbayatyDennis BrooksRosalinda H ArendsJohn TillinghastAnastasia A AksyukJerome BouquetCecil ChenAsfiha GebreRobert J KubiakVenkatesh Pilla ReddySeth SeegobinKatie StreicherAlison TempletonMark T Esser

Published in: The Journal of infectious diseases (2023)

NCT04507256 (https://clinicaltrials.gov/ct2/show/NCT04507256).

Keyphrases

sars cov
image quality
computed tomography
respiratory syndrome coronavirus
dual energy
open label
contrast enhanced
dengue virus
magnetic resonance imaging
magnetic resonance
double blind
placebo controlled
zika virus